CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ³ëÁ¾·Ä
  • °©»ó¼±¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : µÎ°æºÎ¾Ï,°©»ó¼±¼ö¼ú,¸ñÁúȯ,À½¼ºÀå¾Ö,³»½Ã°æ-·Îº¿¼ö¼ú
  • Á÷ À§: ±³¼ö(°©»ó¼±¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
212 ÇØ¿Ü Roh JL, Kim SA. Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer. 2016 Mar 15;122(6):972-3. (Corresponding author) (A letter to the Editor)  
211 ÇØ¿Ü Moon H, Roh JL, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy. Radiother Oncol. 2016 Feb;118(2):330-4. (Corresponding author)  
210 ÇØ¿Ü Kim JW, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY. Treatment Outcomes and Risk Factors for Recurrence after Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma. Thyroid. 2016 Feb;26(2):262-270 (Corresponding author)  
209 ÇØ¿Ü Kwon M, Moon H, Nam SY, Lee JH, Kim JW, Lee YS, Roh JL, Choi SH, Kim SY. Clinical significance of three-dimensional measurement of tumour thickness on magnetic resonance imaging in patients with oral tongue squamous cell carcinoma. Eur Radiol. 2015 Mar;26(3):858-865.  
208 ÇØ¿Ü Yang CJ, Roh JL, Kim MJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer. Quality Life Res. 2016 Jan;25(1):165-174 (Corresponding author)  
207 ÇØ¿Ü Roh JL, Park JY, Kim EH, Jang HJ, Kwon M. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Cancer Lett. 2016 Feb;371(1):20-29 (Corresponding author)  
206 ÇØ¿Ü Kang HS, Roh JL, Kim KJ, Cho KJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment. J Cancer Res Clin Oncol. 2016 Jan;142(1):295-304 (Corresponding author)  
205 ÇØ¿Ü Roh JL, Park JY, Kim EH, Jang HJ. Targeting acid ceramidase sensitizes head and neck cancer to cisplatin. Eur J Cancer. 2016 Jan;52(1):163-172 (Corresponding author)  
204 ÇØ¿Ü Kim SA, Roh JL, Lee SA, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer. 2016 Jan;122(1):131-140 (Corresponding author)  
203 ÇØ¿Ü Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY. Prognostic factors and outcome analysis of salivary duct carcinoma. Auris Nasus Larynx. 2015 Dec;42(6):472-7.  
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729